Everyday health

Living every day with COPD

How we do business

Pulling back the curtain on the PBS

GSK and ViiV Healthcare aim to ‘pull back the curtain’ on the PBS with a video and report that explain how the Government assesses new medicines and vaccines.

Everyday health

Digital healthcare attitudes in Australia

How we do business

PharmAus 2017: Showcasing the health and economic benefits of innovation in medicines

The inaugural PharmAus showcase saw GSK and 19 other innovative pharmaceutical companies illustrate our industry’s investment and collaboration with Australia’s top research institutes, universities, biotechs and patients, to deliver the latest breakthroughs in treatment.

Innovation

Investing in our future

Our people

Philip Leslie

Access to healthcare

Understanding of COPD improved through GSK supported independent medical education program

Access to healthcare

No 'silver bullet' to tackle this disease

Dr Sophie Biernaux, talks about GSK's commitment to fighting malaria.

Innovation

Bioelectronics

GSK's Bioelectronics R&D unit is pursuing a relatively new scientific field that could one day result in a new class of medicines that would not be pills or injections but miniaturised, implantable devices.

Access to healthcare

Giving babies a healthier start

Why are our scientists researching how to adapt an ingredient in mouthwash into a gel for newborn babies?

Our Community

Play-based learning for Australian kids

Every child has the right to a healthy, educated and safe future. Sadly, this is not the reality for all children. Some children drop out of school or have poor attendance because they don’t have the basic learning foundation to continue their education journey.

Access to healthcare

Malaria

Our people

Isaac Barr

How we do business

Open source: the future of medical discovery

There is growing recognition that no single research body or group has the know-how or resources to tackle the most widespread and persistent diseases. Fortunately, a growing number of scientists are engaged in open source innovation that removes barriers and creates a more transparent environment for medical discovery.

How we do business

Crowd sourcing new treatments for malaria

New medicines are urgently needed for diseases of the developing world and those medicines need to be affordable.

Innovation

Australian innovation pilot aims to reduce cost of vaccination in developing world

GSK has invested $7.7 million in a new pilot vaccine facility with the hope Australian manufacturing innovation could reduce cost of vaccination in developing world.

Access to healthcare

The fight against malaria

For the past 30 years, GSK scientists have been working with other organisations across the globe with the aim to develop what could be the world’s first malaria vaccine.

How we do business

Harnessing the electrical language of the body to treat disease

Access to healthcare

A rapid response to slow acting disasters

How we do business

Fostering excellence in respiratory research

GSK has been a significant supporter of The George Institute for Global Health for a number of years and we’ve recently contributed $161,000 to support a research fellow in respiratory medicine.

Environment

Reducing our carbon footprint

Reducing our carbon footprint while addressing health access in neighbouring, less developed countries.

Our Community

Volunteering in Kenya

Through GSK’s PULSE Volunteer Partnership, our employees can use their professional skills to help create sustainable change for our non-profit partners and the communities they serve.

Our Community

NYSF - inspiring the next generation of scientists

With much of the world’s future innovation to come from science, technology, engineering and maths (STEM), it is very important that the innovators of tomorrow are supported and mentored.

Our Community

Keeping our Olympic athletes healthy and ready to compete in Rio

Our Community

Victoria Police - Trek of a lifetime

Our Community

Polio Australia - support of polio retreat to help those affected

Polio is a disease that has virtually been forgotten by our community. Although vaccination implemented in Australia in the late 1950s has prevented new infections, polio survivors form the largest single physical disability group in the country.

Everyday health

Every breathe you take: Alannah's story

Most of us take breathing for granted. It’s an automatic activity that we don’t need to think about. But imagine if every breath you took was a struggle; imagine waking up in the night wheezing and short of breath.

Our Community

Employees helping communities

Our people and the communities in which they operate are essential to our success. We focus on building their individual capabilities and aim to support and empower them to be the best they can be.

Everyday health

Keep moving - Jan's story

Jan was diagnosed with osteoarthritis after noticing aches and pains while swimming and carrying out my daily activities. Jan shares how this osteoarthritis has affected her life and how she manages the pain and inflammation brought about by this condition.

Access to healthcare

Increasing medicine access across the world's poorest nations

Our people

Mark Lambert

Our people

Annette Gross

Annette Gross is recognised as a leading expert in Ethnopharmacology. Her team looks at differences in drug response across ethnic groups.

Our people

Lisa Bonadonna

Australian Lisa Bonadonna lives in Europe heading up GSK's global partnership with Save the Children.

Our people

Laura Ljubanovic

Laura talks about her experience stepping up from legal counsel to Head of the Legal Department at GSK Australia on International Women's Day 2016.

Our people

Rachel Bradley

Rachael Bradley from our Consumer Healthcare team explains what she loves about building brand love for Panadol and why GSK is a great place to work.

Environment

Trusted partnership achieves supply chain improvements

Everyday health

Living with COPD: Peter's story

Access to healthcare

International collaboration seeks to make childbirth safer in developing countries

A global alliance led by GSK and Monash University promises to fast-track delivery of oxytocin to mothers in developing countries

Our Community

A comic book on vaccines

Immunisation rates among Australian children has risen significantly over the years. However, there remains a distinct disparity between children from Aboriginal and Torres Strait Islander communities and other Australians.

Innovation

Innovation and collaboration with Monash University

Our Community

Save the Children

GSK and Save the Children have the goal of helping to save the lives of one million children by sharing medical and humanitarian expertise.

Back to top